Artificial intelligence (AI) in point-of-care testing

IF 3.2 3区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY
Tahir S. Pillay , Adil I. Khan , Sedef Yenice
{"title":"Artificial intelligence (AI) in point-of-care testing","authors":"Tahir S. Pillay ,&nbsp;Adil I. Khan ,&nbsp;Sedef Yenice","doi":"10.1016/j.cca.2025.120341","DOIUrl":null,"url":null,"abstract":"<div><div>The integration of artificial intelligence (AI) into point-of-care testing (POCT) represents a transformative leap in modern healthcare, addressing critical challenges in diagnostic accuracy, workflow efficiency, and equitable access. While POCT has revolutionized decentralized care through rapid results, its potential is hindered by variability in accuracy, integration hurdles, and resource constraints. AI technologies—encompassing machine learning, deep learning, and natural language processing—offer robust solutions: convolutional neural networks improve malaria detection in sub-Saharan Africa to 95 % sensitivity, while predictive analytics reduce device downtime by 20 % in resource-limited settings. AI-driven decision support systems curtail antibiotic misuse by 40 % through real-time data synthesis, and portable AI devices enable anaemia screening in rural India with 94 % accuracy, slashing diagnostic delays from weeks to hours. Despite these advancements, challenges persist, including data privacy risks, algorithmic opacity, and infrastructural gaps in low- and middle-income countries. Explainable AI frameworks and blockchain encryption are critical to building clinician trust and ensuring regulatory compliance. Future directions emphasize the convergence of AI with Internet of Things (IoT) and blockchain for predictive diagnostics, as demonstrated by AI-IoT systems forecasting dengue outbreaks 14 days in advance. Personalized medicine, powered by genomic and wearable data integration, further underscores AI potential to tailor therapies, reducing cardiovascular events by 25 %. Realizing this vision demands interdisciplinary collaboration, ethical governance, and equitable implementation to bridge global health disparities. By harmonizing innovation with accessibility, AI-enhanced POCT emerges as a cornerstone of proactive, patient-centered healthcare, poised to democratize diagnostics and drive sustainable health equity worldwide.</div></div>","PeriodicalId":10205,"journal":{"name":"Clinica Chimica Acta","volume":"574 ","pages":"Article 120341"},"PeriodicalIF":3.2000,"publicationDate":"2025-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Chimica Acta","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009898125002207","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The integration of artificial intelligence (AI) into point-of-care testing (POCT) represents a transformative leap in modern healthcare, addressing critical challenges in diagnostic accuracy, workflow efficiency, and equitable access. While POCT has revolutionized decentralized care through rapid results, its potential is hindered by variability in accuracy, integration hurdles, and resource constraints. AI technologies—encompassing machine learning, deep learning, and natural language processing—offer robust solutions: convolutional neural networks improve malaria detection in sub-Saharan Africa to 95 % sensitivity, while predictive analytics reduce device downtime by 20 % in resource-limited settings. AI-driven decision support systems curtail antibiotic misuse by 40 % through real-time data synthesis, and portable AI devices enable anaemia screening in rural India with 94 % accuracy, slashing diagnostic delays from weeks to hours. Despite these advancements, challenges persist, including data privacy risks, algorithmic opacity, and infrastructural gaps in low- and middle-income countries. Explainable AI frameworks and blockchain encryption are critical to building clinician trust and ensuring regulatory compliance. Future directions emphasize the convergence of AI with Internet of Things (IoT) and blockchain for predictive diagnostics, as demonstrated by AI-IoT systems forecasting dengue outbreaks 14 days in advance. Personalized medicine, powered by genomic and wearable data integration, further underscores AI potential to tailor therapies, reducing cardiovascular events by 25 %. Realizing this vision demands interdisciplinary collaboration, ethical governance, and equitable implementation to bridge global health disparities. By harmonizing innovation with accessibility, AI-enhanced POCT emerges as a cornerstone of proactive, patient-centered healthcare, poised to democratize diagnostics and drive sustainable health equity worldwide.
人工智能(AI)在护理点测试
将人工智能(AI)集成到护理点测试(POCT)中代表了现代医疗保健的变革性飞跃,解决了诊断准确性、工作流程效率和公平访问方面的关键挑战。虽然POCT通过快速结果彻底改变了分散式护理,但其潜力受到准确性差异、整合障碍和资源限制的阻碍。人工智能技术——包括机器学习、深度学习和自然语言处理——提供了强大的解决方案:卷积神经网络将撒哈拉以南非洲地区的疟疾检测灵敏度提高到95%,而预测分析在资源有限的情况下将设备停机时间减少了20%。人工智能驱动的决策支持系统通过实时数据合成将抗生素滥用减少了40%,便携式人工智能设备使印度农村的贫血筛查准确率达到94%,将诊断延误从数周减少到数小时。尽管取得了这些进步,但挑战依然存在,包括数据隐私风险、算法不透明以及低收入和中等收入国家的基础设施差距。可解释的人工智能框架和区块链加密对于建立临床医生信任和确保法规遵从性至关重要。未来的方向强调人工智能与物联网(IoT)和区块链的融合,以进行预测诊断,正如人工智能-物联网系统提前14天预测登革热疫情所证明的那样。由基因组和可穿戴数据集成提供支持的个性化医疗进一步凸显了人工智能在定制治疗方面的潜力,可将心血管事件减少25%。实现这一愿景需要跨学科合作、道德治理和公平实施,以弥合全球卫生差距。通过协调创新和可及性,人工智能增强的POCT成为积极主动、以患者为中心的医疗保健的基石,有望使诊断民主化,推动全球可持续的卫生公平。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinica Chimica Acta
Clinica Chimica Acta 医学-医学实验技术
CiteScore
10.10
自引率
2.00%
发文量
1268
审稿时长
23 days
期刊介绍: The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells. The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal''s scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信